Publication Beamlines Strategic Pillar
Blanchard, Peter E.R.; Van Loon, Lisa L.; Reid, Joel W.; Cutler, Jeffrey N.; Rowson, John et al. (2017). Investigating arsenic speciation in the JEB Tailings Management Facility at McClean Lake, Saskatchewan using X-ray absorption spectroscopy. Chemical Geology 466, 617-626. 10.1016/j.chemgeo.2017.07.014. CMCF-BM, HXMA Environment
Blanchard, Peter E.R.; Van Loon, Lisa L.; Reid, Joel W.; Cutler, Jeffrey N.; Rowson, John et al. (2017). Investigating arsenic speciation in the JEB Tailings Management Facility at McClean Lake, Saskatchewan using X-ray absorption spectroscopy. Chemical Geology 466, 617-626. 10.1016/j.chemgeo.2017.07.014. CMCF-BM, HXMA Environment
Clifton, Matthew C.; Dranow, David M.; Leed, Alison; Fulroth, Ben; Fairman, James W. et al. (2015). A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1. PLoS ONE 10(4) , e0125010. 10.1371/journal.pone.0125010. [PDB: 4wmu] CMCF-ID Health
Dorothea Kominos; Jie Zhang; Alla PRITSKER; Matthew Davison; Nicolas Baurin et al. (2015). Antibodies to bradykinin b1 receptor ligands. Patent Number: EP2831113A1. CMCF-ID Health
Duclos, Franck; Abell, Lynn M.; Harden, David G.; Pike, Kristen; Nowak, Kimberly et al. (2017). Triazolopyrimidines identified as reversible myeloperoxidase inhibitors. MedChemComm 8(11) , 2093-2099. 10.1039/c7md00268h. [PDB: 5wdj] CMCF-ID Health
Eastman, Kyle J.; Parcella, Kyle; Yeung, Kap-Sun; Grant-Young, Katharine A.; Zhu, Juliang et al. (2017). The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymerase. MedChemComm 8(4) , 796-806. 10.1039/c6md00636a. [PDB: 5twn] CMCF-ID Health
Gayda, Susan; Longenecker, Kenton L.; Judge, Russell A.; Swift, Kerry M.; Manoj, Sharmila et al. (2016). Three-dimensional structure, binding, and spectroscopic characteristics of the monoclonal antibody 43.1 directed to the carboxyphenyl moiety of fluorescein. Biopolymers 105(4) , 234-243. 10.1002/bip.22801. [PDB: 5dyo] CMCF-ID Health
Hackos, David H.; Lupardus, Patrick J.; Grand, Teddy; Chen, Yelin; Wang, Tzu-Ming et al. (2016). Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function. Neuron 89(5) , 983-999. 10.1016/j.neuron.2016.01.016. [PDB: 5h8h] CMCF-ID Health
Hynes, John; Wu, Hong; Kempson, James; Duan, James J.-W.; Lu, Zhonghui et al. (2017). Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors. Bioorganic and Medicinal Chemistry Letters 27(14) , 3101-3106. 10.1016/j.bmcl.2017.05.043. [PDB: 5vo6] CMCF-ID Health
Jarvis, Thale C.; Davies, Douglas R.; Hisaminato, Akihiko; Resnicow, Daniel I.; Gupta, Shashi et al. (2015). Non-helical DNA Triplex Forms a Unique Aptamer Scaffold for High Affinity Recognition of Nerve Growth Factor. Structure 23(7) , 1293-1304. 10.1016/j.str.2015.03.027. [PDB: 4zbn] CMCF-ID Health
Kodandaram Pillarisetti; Eric Thomas BALDWIN; Gordon D. Powers; Rosa Maria Fernandes CARDOSO; Ricardo Attar et al. (2017). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: WO2017031104A1. CMCF-ID Health
Malia, Thomas J.; Teplyakov, Alexey; Ernst, Robin; Wu, Sheng‐Jiun; Lacy, Eilyn R. et al. (2016). Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti‐tau antibody AT8. Proteins: Structure. Function and Bioinformatics 84(4) , 427-434. 10.1002/prot.24988. [PDB: 5e2w] CMCF-ID Health
Michael M. Schmidt; Sharon TOWNSON; Thomas M. Barnes (2014). Albumin variants binding to fcrn. Patent Number: WO2014179657A1. CMCF-ID Health
Ndubaku, Chudi O.; Crawford, James J.; Drobnick, Joy; Aliagas, Ignacio; Campbell, David et al. (2015). Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pKa Polar Moiety. ACS Medicinal Chemistry Letters 6(12) , 1241-1246. 10.1021/acsmedchemlett.5b00398. CMCF-ID Health
Ndubaku, Chudi O.; Crawford, Terry D.; Chen, Huifen; Boggs, Jason W.; Drobnick, Joy et al. (2015). Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis. ACS Medicinal Chemistry Letters 6(8) , 913-918. 10.1021/acsmedchemlett.5b00174. CMCF-ID Health